Bokyung Kim

Prof. Bokyung Kim

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2006 in Proteomics
Verified
Journal Article
Closed access
PDF file
CLChang‐Kwon Lee
Chang‐Kwon Lee
HPHyo‐Jun Park
Hyo‐Jun Park
HSHyeon Ha So
Hyeon Ha So
HKHyo Jin Kim
Hyo Jin Kim
KLKeun Sang Lee
Keun Sang Lee
BKBokyung Kim
Bokyung Kim

30 January 2009 in Circulation Research
Verified
Journal Article
Closed access
HLHwan Myung Lee
Hwan Myung Lee
Byeong Hwa JeonByeong Hwa Jeon
Byeong Hwa Jeon
KWKyung-Jong Won
Kyung-Jong Won
CLChang-Kwon Lee
Chang-Kwon Lee
TPTae-Kyu Park
Tae-Kyu Park
BKBokyung Kim
Bokyung Kim
The role of apurinic/apyrimidinic endonuclease-1/redox factor-1 (Ref-1) in vascular smooth muscle cells has yet to be clearly elucidated. Therefore, we attempted to determine the roles of Ref-1 in the migration induced by platelet-derived growth factor (PDGF)-BB and in its signaling in rat aortic smooth muscle cells (RASMCs). Cellular migration, superoxide (O 2 −· ) production, Rac-1 activity, and neointima formation were determined in cells transfected with adenoviruses encoding for Ref-1 (AdRef-1) and small interference RNA of Ref-1. Overexpression of Ref-1 induced by treatment with RASMCs coupled with AdRef-1 inhibited the migration induced by PDGF-BB. PDGF-BB also increased the phosphorylation of the PDGFβ receptor, spleen tyrosine kinase (Syk), mitogen-activated protein kinase, and heat shock protein 27, but these increases were significantly inhibited by AdRef-1 treatment. PDGF-BB increased O 2 −· production and Rac-1 activity, and these were diminished in cells transfected with AdRef-1. In contrast, RASMC migration, phosphorylation of Syk and O 2 −· production in response to PDGF-BB were increased by the knock down of Ref-1 with small interference RNA. The phosphorylation of PDGFβ receptor in response to PDGF-BB was inhibited completely by the Syk inhibitor and was partly attenuated by a NADPH oxidase inhibitor. PDGF-BB increased the sprout outgrowth of the aortic ring ex vivo, which was inhibited in the AdRef-1–infected RASMCs as compared with the controls. Balloon injury–induced neointimal formation was significantly attenuated by the gene transfer of AdRef-1. These results indicate that Ref-1 inhibits the PDGF-mediated migration signal via the inhibition of reactive oxygen species–mediated Syk activity in RASMCs.

Verified
Journal Article
Open access
PDF file
YRYunkyoung Ryu
Yunkyoung Ryu
DLDonghyen Lee
Donghyen Lee
SJSeung Hyo Jung
Seung Hyo Jung
KLKyung-Jin Lee
Kyung-Jin Lee
HJHengzhe Jin
Hengzhe Jin
KWKyung Jong Won
Kyung Jong Won
Chrysanthemum boreale Makino essential oil (CBMEO) has diverse biological activities including a skin regenerating effect. However, its role in muscle atrophy remains unknown. This study explored the effects of CBMEO and its active ingredients on skeletal muscle atrophy using in vitro and in vivo models of muscle atrophy. CBMEO reversed the size decrease of L6 myoblasts under starvation. Among the eight monoterpene compounds of CBMEO without cytotoxicity for L6 cells, sabinene induced predominant recovery of reductions of myotube diameters under starvation. Sabinene diminished the elevated E3 ubiquitin ligase muscle ring-finger protein-1 (MuRF-1) expression and p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase1/2 (ERK1/2) phosphorylations in starved myotubes. Moreover, sabinene decreased the increased level of reactive oxygen species (ROS) in myotubes under starvation. The ROS inhibitor antagonized expression of MuRF-1 and phosphorylation of MAPKs, which were elevated in starved myotubes. In addition, levels of muscle fiber atrophy and MuRF-1 expression in gastrocnemius from fasted rats were reduced after administration of sabinene. These findings demonstrate that sabinene, a bioactive component from CBMEO, may attenuate skeletal muscle atrophy by regulating the activation mechanism of ROS-mediated MAPK/MuRF-1 pathways in starved myotubes, probably leading to the reverse of reduced muscle fiber size in fasted rats.

1 January 2009 in The Korean Journal of Physiology & Pharmacology
Verified
Journal Article
Open access
PDF file
JKJunghwan Kim
Junghwan Kim
KWKyung-Jong Won
Kyung-Jong Won
HLHwan Myung Lee
Hwan Myung Lee
BHByong-Yong Hwang
Byong-Yong Hwang
YBYoung-Min Bae
Young-Min Bae
BKBokyung Kim
Bokyung Kim
Kim J, et al. Korean J Physiol Pharmacol. 2009 Dec;13(6):491-496. http://dx.doi.org/10.4196/kjpp.2009.13.6.491

18 May 2010 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HYHee Yi
Hee Yi
HCHee-Jung Cho
Hee-Jung Cho
SCSoo-Min Cho
Soo-Min Cho
DLDong-Goo Lee
Dong-Goo Lee
A. M. Abd El-AtyA. M. Abd El-Aty
A. M. Abd El-Aty
HSHo-Chul Shin
Ho-Chul Shin
Background: We have studied the in vitro and in vivo utility of polyethylene glycol (PEG)-hydrogels for the development of an anticancer drug 5-fluorouracil (5-FU) delivery system. Methods: A 5-FU-loaded PEG-hydrogel was implanted subcutaneously to evaluate the drug retention time and the anticancer effect. For the pharmacokinetic study, two groups of male rats were administered either an aqueous solution of 5-FU (control group)/or a 5-FU-loaded PEG-hydrogel (treated group) at a dose of 100 mg/kg. For the pharmacodynamic study, a human non-small-cell lung adenocarcinoma (NSCLC) cell line, A549 was inoculated to male nude mice with a cell density of 3 × 106. Once tumors start growing, the mice were injected with 5-FU/or 5-FU-loaded PEG-hydrogel once a week for 4 weeks. The growth of the tumors was monitored by measuring the tumor volume and calculating the tumor inhibition rate (IR) over the duration of the study. Results: In the pharmacokinetic study, the 5-FU-loaded PEG-hydrogel gave a mean residence time (MRT) of 8.0 h and the elimination half-life of 0.9 h; these values were 14- and 6-fold, respectively, longer than those for the free solution of 5-FU (p < 0.05). In the pharmacodynamic study, A549 tumor growth was significantly inhibited in the 5-FU-loaded PEG-hydrogel group in comparison to the untreated group beginning on Day 14 (p < 0.05-0.01). Moreover, the 5-FU-loaded PEG-hydrogel group had a significantly enhanced tumor IR (p < 0.05) compared to the free 5-FU drug treatment group. Conclusion: We suggest that 5-FU-loaded PEG-hydrogels could provide a useful tool for the development of an anticancer drug delivery system.

1 August 2014 in Atherosclerosis
Verified
Journal Article
Closed access
SJSeung Hyo Jung
Seung Hyo Jung
KWKyung Jong Won
Kyung Jong Won
KLKang Pa Lee
Kang Pa Lee
DLDong Hyun Lee
Dong Hyun Lee
SYSuyeol Yu
Suyeol Yu
BKBokyung Kim
Bokyung Kim